Supply Chain Readies to Deliver 9 Million COVID-19 Vaccines Per Day, Marking 2021 as the Year of Cold Chain Logistics

OYSTER BAY, N.Y., Dec. 8, 2020 /PRNewswire/ -- As the world awaits the approval of COVID-19 vaccines, the worldwide freight industry is gearing up for an initial 2021 goal of transporting an average of 271 million ultracold and cold doses per month (9 million doses per day). Early modeling by global tech market advisory firm, ABI Research shows that there will be at least 857 temperature-controlled trucks leaving Pfizer and Moderna manufacturing facilities or distribution centers each month. Should AstraZeneca also receive approval, these numbers will be materially increased. Distribution and delivery will continue to grow and get more complicated after the large urban and suburban areas are covered.

In its new whitepaper, 68 Technology Trends That Will Shape 2021, ABI Research's analysts identify 37 trends that will shape the technology market and 31 others that, although attracting huge amounts of speculation and commentary, are less likely to move the needle over the next twelve months. "For success in 2021, especially after a very challenging 2020, one must understand fundamental trends early, and take a view on those trends that are buoyed by hyperbole and those that are sure to be uncomfortable realities. Now is the time to double down on the right technology investment," says Stuart Carlaw, Chief Research Officer at ABI Research.

What Will Happen in 2021:

Vaccine Freezer Frenzy
"Early vaccine candidates require ultra-low temperatures, as much as -70 degrees Celsius ©, or -94 Fahrenheit. This is impacted by a lack of adequate storage capacity for these new types of Messenger RNA (mRNA) vaccines. The containers to store and transport them are not widely available and not required for common vaccines. Constant temperature control is needed from the manufacturing site to the inoculation sites. According to known criteria, people will require two vaccines from the same manufacturer within 21-28 days. That equates to at least 662 million doses in the United States and approximately 1.5 billion across the European Union," explains Susan Beardslee, Freight Transportation and Logistics Principal Analyst at ABI Research.

Much of the focus, to date, has been on fulfilment centers and modal capacity for air. Another concern is the need to seamlessly track temperatures and provide alerts for any out-of-spec loads. This involves integrated software, sufficient compute and sensor capabilities throughout, and the cooperation of both public and private entities across multiple modes and likely competitors. "The scale of technology, strategy, and operations excellence needed will require transparency, flexibility, and scale never seen, and will take herculean efforts beyond the actual vaccine development and approval," Beardslee points out.

What Won't Happen in 2021:

No Global Supply Chain Return to the "Before Times"
"Although goods transportation has seen a promising rebound from the spring, pinch points continue, from driver shortages (back to 2018 levels) to container shortages and carrier bankruptcies due to increasing insurance costs and lower profits. Further digitization and integration of systems will provide greater visibility, flexibility, and ROI to supply chain participants that can improve economic performance, but likely after 2021 on a broader scale," Beardslee explains.

For more trends that will – and won't - happen in 2021, download the whitepaper, 68 Technology Trends that Will Shape 2021: Predictions for What Will and Will Not Happen in The Year Ahead. 

About ABI Research
ABI Research provides strategic guidance to visionaries, delivering actionable intelligence on the transformative technologies that are dramatically reshaping industries, economies, and workforces across the world. ABI Research's global team of analysts publish groundbreaking studies often years ahead of other technology advisory firms, empowering our clients to stay ahead of their markets and their competitors. 

ABI Research提供开创性的研究和战略指导，帮助客户了解日新月异的技术。 自1990年以来，我们已与全球数百个领先的技术品牌，尖端公司，具有远见的政府机构以及创新的贸易团体建立了合作关系。 我们帮助客户创造真实的业务成果。 

For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com.

Contact Info: 

Global                                                             
Deborah Petrara                                                           
Tel: +1.516.624.2558                                                    
[email protected]   

SOURCE ABI Research

Related Links

http://www.abiresearch.com